Back
Novo Nordisk AS Stock Predictions
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
34
NONOF
Novo Nordisk AS
Last Price:
105.49
Seasonality Move:
10.92%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereNovo Nordisk AS Stock Forecast
- Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 24.2% based on the past 15 years of stock performance.
- Novo Nordisk AS has risen higher in 12 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Novo Nordisk AS Stock Undervalued?
The current Novo Nordisk AS [NONOF] share price is $105.49. The Score for NONOF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal. - NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk AS Stock Go Up Next Year?
- Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 24.2% based on the past 15 years of stock performance.
Novo Nordisk AS Stock Rating
Sell
34
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS overpriced?
- Novo Nordisk AS has risen higher in 12 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Novo Nordisk AS Stock Price History
Stock Information
Stock Info
Exchange:
OTCM
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
149.55
52-Week Low:
94.36
Prediction Charts
Market Cap:
468.73B
Price in USD:
105.49
Volume:
54.89K
Beta:
0.51
Technical Analysis
SMA50:
116.71
SMA100:
125.39
SMA200:
127.84
52-Wk Change:
1.68%
Stock Predictions
-
Is Novo Nordisk AS stock public?
Yes, Novo Nordisk AS is a publicly traded company. -
What is the Novo Nordisk AS stock quote today?
The Novo Nordisk AS stock price is 105.49 USD today. -
How to buy Novo Nordisk AS stock online?
You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-1 | 115.29 | 111.54 | 115.29 | 109.00 |
| Nov-4 | 114.55 | 109.80 | 114.55 | 107.79 |
| Nov-5 | 110.48 | 106.21 | 112.15 | 105.00 |
| Nov-6 | 104.35 | 110.60 | 112.50 | 104.35 |
| Nov-7 | 110.00 | 106.01 | 110.25 | 106.00 |
| Nov-8 | 102.90 | 110.70 | 111.20 | 102.90 |
| Nov-11 | 113.23 | 107.81 | 113.90 | 107.80 |
| Nov-12 | 107.99 | 105.43 | 108.84 | 104.57 |
| Nov-13 | 104.11 | 104.81 | 110.00 | 103.00 |
| Nov-14 | 110.90 | 105.79 | 110.90 | 104.26 |
| Nov-15 | 104.23 | 102.20 | 105.00 | 99.37 |
| Nov-18 | 102.00 | 101.21 | 103.99 | 98.03 |
| Nov-19 | 98.75 | 101.21 | 105.00 | 98.75 |
| Nov-20 | 101.28 | 105.49 | 107.00 | 99.65 |
Novo Nordisk AS Earnings
Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk AS Forecast Revenue Growth
Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.